Mechanistically, loss of SUZ12 function has been reported to promote angiogenesis and tumor progression in T-cell acute lymphoblastic leukemia (T-ALL) through modulation of the VEGF signaling pathway (Broux et al., 2019). Here, VEGFA is linked to neoplasm.